SLCO1B1 and myopathy: Further study reported a significant association between patients carried SLCO1B1 T521C and myopathy induced by statins, including simvastatin, rosuvastatin and ceruvastatin (Xiang et al., 2018; Carr et al., 2019; Turner et al., 2020).